MyFinsight
Home
Blog
About
Contact
Download
Download image
North American
Pharmaceutical...
$336,652M
Oncology And
Multispecialty...
$48,423M
Medical Surgical
Solutions...
$11,507M
(1.06%↑ Y/Y)
Operating
Segments-Prescription Technology...
$5,805M
(11.29%↑ Y/Y)
Material Reconciling
Items
$1,043M
Revenues
$403,430M
(12.36%↑ Y/Y)
Gross profit
$14,550M
(9.21%↑ Y/Y)
Cost of sales
$388,880M
(12.48%↑ Y/Y)
Operating income
$6,212M
(40.48%↑ Y/Y)
Other income, net
$236M
(16.83%↑ Y/Y)
Total operating
expenses
$8,338M
(-6.33%↓ Y/Y)
Claims and litigation
charges, net
$3M
(102.78%↑ Y/Y)
Income before income
taxes
$6,201M
Interest expense
$247M
(-6.79%↓ Y/Y)
Selling, distribution,
general, and...
$8,096M
(-4.83%↓ Y/Y)
Restructuring, impairment, and
related charges, net
$245M
(-14.34%↓ Y/Y)
Net income
$5,099M
(46.48%↑ Y/Y)
Income tax expense
$1,102M
(25.51%↑ Y/Y)
Net income
attributable to mckesson...
$4,762M
(44.52%↑ Y/Y)
Net income
attributable to...
$337M
(81.18%↑ Y/Y)
Back
Back
Income Statement
mck_logo_blue-svg
MCKESSON CORP (MCK)
mck_logo_blue-svg
MCKESSON CORP (MCK)
source: myfinsight.com